Your browser doesn't support javascript.
loading
[IMMUNOTHERAPY WITH CHECKPOINT INHIBITORS (ICPI) AND IMMUNE RELATED ADVERSE EVENTS (IRAE'S)].
Ben Zvi, Carina; Ehrenfeld, Michael; Shoenfeld, Yehuda.
Affiliation
  • Ben Zvi C; Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
  • Ehrenfeld M; Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
  • Shoenfeld Y; Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel.
Harefuah ; 159(7): 508-515, 2020 Jul.
Article in He | MEDLINE | ID: mdl-32720769
Subject(s)
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Immunotherapy / Neoplasms Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans Language: He Journal: Harefuah Year: 2020 Type: Article Affiliation country: Israel
Search on Google
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Immunotherapy / Neoplasms Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Humans Language: He Journal: Harefuah Year: 2020 Type: Article Affiliation country: Israel